Candidate genetic markers and therapeutic targets in hereditary and sporadic prostate cancer

被引:0
|
作者
Berthon, P [1 ]
机构
[1] UroGene, F-91058 Evry, France
来源
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [31] Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features
    Alberti, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (01) : 31 - 41
  • [32] Potential differences in the clinicopathological profile of familial/hereditary and sporadic prostate cancer
    Kupesiz, Gokben Yildirim
    Powell, Isaac
    Grignon, David
    Sakr, Wael
    VIRCHOWS ARCHIV, 2007, 451 (02) : 418 - 418
  • [33] Genetic analysis of potential markers and therapeutic targets for immunity in periodontitis
    Li, Hui
    Du, Wanqing
    Ye, Xin
    Luo, Xi
    Duan, Xuejing
    FRONTIERS IN DENTAL MEDICINE, 2024, 5
  • [34] Impact of Genetic Targets on Prostate Cancer Therapy
    Sheikh, Hassan
    Abdulghani, Junaid
    Ali, Suhail
    Sinha, Raghu
    Lipton, Alan
    IMPACT OF GENETIC TARGETS ON CANCER THERAPY, 2013, 779 : 359 - 383
  • [35] Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci
    Brown, WM
    Lange, EM
    Chen, H
    Zheng, SL
    Chang, B
    Wiley, KE
    Isaacs, SD
    Walsh, PC
    Isaacs, WB
    Xu, J
    Cooney, KA
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 510 - 514
  • [36] Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci
    W M Brown
    E M Lange
    H Chen
    S L Zheng
    B Chang
    K E Wiley
    S D Isaacs
    P C Walsh
    W B Isaacs
    J Xu
    K A Cooney
    British Journal of Cancer, 2004, 90 : 510 - 514
  • [37] Hereditary and sporadic ovarian cancer: Genetic testing and clinical implications (review)
    Angioli, R
    Estape, R
    Mason, M
    Penalver, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (05) : 1029 - 1034
  • [38] Proteomics of breast cancer: The quest for markers and therapeutic targets
    Hondermarck, Hubert
    Tastet, Christophe
    El Yazidi-Belkoura, Lkram
    Toillon, Robert-Alain
    Le Bourhis, Xuefen
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (04) : 1403 - 1411
  • [39] Medullary thyroid cancer: therapeutic targets and molecular markers
    Ball, Douglas W.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (01) : 18 - 23
  • [40] Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
    Vihinen, P
    Kähäri, VM
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) : 157 - 166